Manipulating the CD80/CD86 pathway may yield new strategies for treating multiple myeloma, new research on dendritic cells suggests. This research focused on the immune system’s dendritic cells (DCs), crucial cells that initiate and regulate immune responses. For example, the dendritic cells activate T lymphocytes to fight an infection or cancer. Curiously, they are also known to suppress the immune response. Determining when DCs turn the immune response “on” or “off” is a major question in immu...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/2...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/2...